Featured Image

Why is it important?

This case is important because dupilumab can rarely be associated with the development of psoriasis or a psoriasis-like rash.

Perspectives

Clinical perspective: Dermatologists need to recognize that a new psoriasis-like rash can occur during dupilumab treatment. The timing, clinical appearance and skin biopsy helped establish the diagnosis.

Dr Grigorios Theodosiou
Region Skane

Read the Original

This page is a summary of: Dupilumab‐Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib, Pediatric Dermatology, May 2026, Wiley,
DOI: 10.1111/pde.70269.
You can read the full text:

Read

Contributors

The following have contributed to this page